The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What Are ...

Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects ...

If you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an excellent place to start. It tracks the performance of the ICE Biotechnology Index, a collection of ...

You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001. An increasingly popular option among retail and institutional investors ...

Any pullbacks in IBB should be bought for long-term equity appreciation. IBB is the iShares Biotechnology ETF. IBB tracks the investment performance of an index composed of U.S.-listed equities in ...

The healthcare sector is poised for strong growth, driven by aging populations, technological advancements, and increased ...

The infrastructure industry is thriving, driven by rising investments in advanced capabilities, increasing demand, and ...

BlackRock is the world's largest asset manager, with $11.5 trillion in client money under its supervision. Around $3.3 ...

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Ishares Nasdaq Biotechnology ETF BDR's revenue for fiscal years ending March 2019 to 2023 averaged 289.1 million. Ishares Nasdaq Biotechnology ETF BDR's operated at median revenue of 294.7 million ...